BPC-157 (Body Protection Compound-157) , otherwise known as bepecin, is a synthetic peptide that is under clinical investigation for numerous therapeutic applications
For a comprehensive overview of the current regulatory environment, read our are research peptides legal in 2026 guide and our FDA peptide reclassification 2026 update
Chronic conditions like long-standing tendinopathy typically require the full 48 week cycle before significant changes are felt
Current research supports strong safety and efficacy indicators , but FDA approval for medical use is pending
In research models, this inhibition indirectly preserves NAD by reducing methylation of nicotinamide, and also maintains SAM levels an effect precursors do not address
There is no risk of dangerous overdose from typical multivitamins alongside the shot, but any more than that (like multiple high-dose supplements) should be avoided